News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - IPO, Updates
Alzheimer's Biotech AC Immune SA Eyes $700 Million IPO Valuation 9/14/2016
Gene Editing Phenom CRISPR Files for $90 Million IPO 9/12/2016
SoCal's Obalon Files for $75 Million IPO 9/12/2016
Honigman Represents Gemphire In $30 Million IPO 8/31/2016
Tech Fund With Focus on Healthcare, Cambridge Innotavion Capital, Scores $98.5 Million 8/23/2016
MabVax Therapeutics Announces The Closing Of Its Public Offering 8/22/2016
AdAlta Pty Ltd. IPO To Accelerate New Therapy For Lung Fibrosis 8/22/2016
A Year After a Scathing Attack By a Short Seller, Cellceutix (CTIX) Eyes the Nasdaq and Big Investors 8/17/2016
Medpace Announces Closing Of Initial Public Offering 8/17/2016
Cincinnati-Based Medpace Prices $161 Million IPO 8/2/2016
North Carolina's Bioventus Postpones $150 Million IPO 8/1/2016
Kadmon Announces Pricing Of Initial Public Offering 7/27/2016
Why Investors are Still Throwing Cash at Debt-Ridden Kadmon, a NYC Biotech Founded By Ex-Con Sam Waksal 7/26/2016
Sensus Healthcare, Inc. Announces Separation Of Units Sold In IPO 7/21/2016
Durham's Patheon (PTI.TO) Moving Forward with $580 Million IPO 7/12/2016
Syros Pharmaceuticals Plans to Take the IPO Plunge Despite Brexit Uncertainty 6/27/2016
With Selecta (SELB)'s $70 Million IPO, Mass Biotechs Raised a Total of $376 Million This Year 6/24/2016
Selecta's IPO Expected Next Week; Sixth Biotech in Massachusetts to Go Public This Year 6/20/2016
Oventus IPO Opens 6/16/2016
Sensus Healthcare (SRTSU) Announces Completion Of Initial Public Offering, Including Underwriters' Exercise Of Over-Allotment Option In Full 6/8/2016
ASCO2016: After NantHealth (NH) Explodes onto the Market, Patrick Soon-Shiong Prepares for Two More 6/6/2016
Moleculin Biotech Completes Nasdaq Initial Public Offering 6/3/2016
Moleculin Biotech, Inc. Completes Initial Public Offering; MBRX Shares Set To Commence Trading On NASDAQ Capital Market June 2, 2016 6/2/2016
Merus (MRUS) Announces Closing Of Initial Public Offering 5/25/2016
ConvaTec Eyes $1 Billion+ IPO 5/17/2016
Viamet Postpones $86 Million IPO 5/12/2016
Backed by Novartis AG (NVS), Viamet Sets Terms for $86 Million IPO 5/4/2016
Poxel Plans To Conduct Registered Initial Public Offering In The United States 5/4/2016
Samsung Biologics Eyes $2.6 Billion IPO in Korea This Year 4/28/2016
CRO Medpace Eyes $1 Billion IPO 4/25/2016
Royal Philips Electronics N.V. (PHG) Falls as Lighting IPO Looks Increasingly Likely 4/25/2016
Aeglea Announces Closing Of Initial Public Offering And Partial Exercise Of The Underwriters’ Option 4/13/2016
Royal Philips Electronics N.V. (PHG) Said to Name Banks for Possible Lighting Unit IPO 4/5/2016
Genprex Takes Baby Steps to Go Public 3/24/2016
Hutchison China MediTech (Chi-Med) Announces Closing Of U.S. Public Offering Of Adss Raising Approximately US$101 Million On The Nasdaq Stock Market 3/22/2016
Senseonics Gears Up for $55.5 Million IPO 3/15/2016
Hutchison China MediTech (Chi-Med) To Complete $100 Million U.S. IPO Next Week 3/8/2016
20/20 GeneSystems Nabs $4.5 Million, Eyes IPO 2/16/2016
Florida's Sensus Healthcare Files for $23 Million IPO for Non-Invasive Skin Cancer Treatments 2/12/2016
Proteostasis (PTI) Debuts Well-Below Expected Range But Still Raises $50 Millon in IPO 2/11/2016
BeiGene Announces Closing Of Its Initial Public Offering 2/9/2016
BeiGene Announces Pricing Of Its Initial Public Offering 2/3/2016
Massachusetts Diagnostic Firm Quanterix Eyes Asia Expansion and Potential IPO This Year 1/27/2016
Gates-Backed Editas Medicine Sets Terms for $122 Million CRISPR IPO 1/26/2016
Mapi Pharma Tries Again to List on Nasdaq, Sets Terms for $50 Million IPO 1/26/2016
PAVmed Dramatically Trims IPO to $6 Million 1/25/2016
Bay Area's First New Public Company of 2016 is OncoCyte 1/4/2016
Therapure Biopharma Inc. Files Preliminary Prospectus For Initial Public Offering 11/30/2015
Axsome Announces Closing Of Initial Public Offering 11/25/2015
REVA Medical Considers IPOing Next Year 11/23/2015
Axsome Announces Pricing Of Initial Public Offering 11/19/2015
Voyager Therapeutics (VYGR) Announces Closing Of Initial Public Offering, Including Full Exercise Of Option To Purchase Additional Shares 11/17/2015
Strongbridge Biopharma Announces Closing Of Initial U.S. Public Offering 10/22/2015
NovoCure Announces Closing Of Partial Exercise Of IPO Over-Allotment Option 10/20/2015
Fourteen Hercules Portfolio Companies Have Completed Or Announced An IPO Or M&A Liquidity Event Year-To-Date 2015 10/20/2015
Advanced Inhalation Therapies Reveals Finances Ahead of $36 Million IPO 10/20/2015
Aclaris (ACRS) Closes $56.5M IPO 10/14/2015
Analysts Closely Watch Bay Area CytomX's $80 Million IPO 10/9/2015
Acelity Expects to Raise $1 Billion in IPO 10/9/2015
NovoCure Announces Closing Of Initial Public Offering 10/8/2015
Edge Therapeutics Announces Closing Of Initial Public Offering And Full Exercise Of Over-Allotment Option 10/7/2015
Mirna Announces Closing Of Initial Public Offering And Concurrent Private Placement With CPRIT 10/6/2015
Shield Therapeutics Postpones IPO Due to Unfavourable Market Conditions 10/5/2015
Bayer (BAY)'s Covestro May Postpone IPO After VW Scandal 10/2/2015
Mirna Announces Pricing Of Its Initial Public Offering 10/1/2015
MyoKardia Eyes $86 Million IPO 9/29/2015
Nabriva Announces Closing Of Its Initial Public Offering 9/24/2015
Penumbra Announces Closing Of Its Initial Public Offering 9/24/2015
REGENXBIO Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 9/23/2015
Strongbridge Biopharma Preps for $76 Million U.S. IPO 9/22/2015
Surgery Partners Valued at Up to $1.25 Billion in IPO 9/21/2015
Mirna Sets Terms For $65 Million IPO 9/18/2015
Mirati Therapeutics  (MRTX) Announces Proposed Public Offering Of $80 Million Of Common Stock 9/15/2015
Bayer (BAY)'s Spinoff Covestro to Go Public in Fourth Quarter 9/4/2015
South San Francisco's CytomX Files for $100 Million IPO 8/31/2015
Constellation Pharma Mulls IPO After Genentech (RHHBY) Declines to Buy 8/26/2015
Acelity Files Registration Statement For Proposed IPO 8/26/2015
Benitec (BLT.AX) Announces Closing Of An Initial Public Offering In The United States With Listing On NASDAQ 8/24/2015
Samsung Bioepis Taps Banks for Planned Nasdaq IPO 8/20/2015
Global Blood Therapeutics (GBT) Announces Closing Of Initial Public Offering And Exercise Of Over-Allotment Option 8/18/2015
Inotek Pharmaceuticals Corporation (ITEK) Announces Pricing Of $68.9 Million Public Offering 8/13/2015
Forbion Announces Two Successful Initial Public Offerings Of Portfolio Companies Pieris And Cellnovo 8/12/2015
Aimmune (AIMT) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 8/12/2015
Global Blood Therapeutics (GBT) Announces Pricing Of Initial Public Offering 8/12/2015
Aimmune Announces Pricing Of Initial Public Offering 8/6/2015
NantKwest Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 8/3/2015
ERYtech Pharma Announces Plans To Conduct Registered Initial Public Offering In The United States 7/28/2015
NantKwest Announces Pricing Of Initial Public Offering 7/28/2015
GC Aesthetics Sets Terms for $75 Million IPO 7/27/2015
vTv Therapeutics Sets Terms for $125 Million IPO 7/20/2015
Cortendo Announces Plans To Conduct Registered Initial Public Offering Of Its Common Shares 7/20/2015
Patrick Soon-Shiong's NantKwest Sets Terms for $151 Million IPO 7/17/2015
Chiasma Prices Initial Public Offering Of Common Stock 7/16/2015
VisionGate Eyes IPO and Plans to Hire 200 New Employees 7/16/2015
Bay Area's Global Blood Therapeutics, Aimmune Jump on the IPO Wagon Seeking $115 Million Each 7/13/2015
Quanterix Sets Sights on IPO 7/8/2015
Seres Therapeutics Announces Closing Of Initial Public Offering 7/2/2015
Catabasis Pharmaceuticals, Inc. Announces Closing Of Initial Public Offering 7/1/2015
ConforMIS Prices $135 Million IPO 7/1/2015
Billionaire Doctor's NantHealth Inches Closer to an IPO 6/30/2015
Glaukos Announces Closing of Its Initial Public Offering 6/30/2015
Ritter Pharmaceuticals, Inc. Announces Closing Of $20,000,000 Initial Public Offering 6/30/2015
Austin Firm Aeglea Files for $86 Million IPO 6/18/2015
Nivalis Therapeutics Set to Debut Tomorrow at $14 Per Share 6/17/2015
Celyad Preps for $99 Million IPO 6/16/2015
Cosmo Pharm Eyes $107 Million+ in Dermatology Unit IPO 6/15/2015
Ligand Pharmaceuticals Inc. (LGND) Summarizes The Accounting Impact Of The Viking Therapeutics (VKTX) IPO And Updates 2015 Financial Guidance 6/3/2015
Ousted Sanofi (SAN.PA) Exec's New Company Aims For $160 Million London IPO 5/27/2015
Galapagos (GLPG.BR) Announces Closing Of NASDAQ IPO 5/20/2015
BiondVax Pharmaceuticals Announces Closing of U.S. IPO 5/15/2015
Arcadia Biosciences (RKDA) Announces Pricing Of Initial Public Offering 5/15/2015
Cystic Fibrosis Biotech Nivalis Therapeutics Files for $60 Million IPO 5/14/2015
aTyr Pharma Announces Closing Of Initial Public Offering 5/13/2015
Collegium (COLL) Announces Closing Of Its IPO And Exercise In Full Of Option To Purchase Additional Shares 5/13/2015
Adaptimmune Announces Closing Of IPO 5/11/2015
aTyr Pharma Announces Pricing Of Initial Public Offering 5/7/2015
Collegium Announces Pricing Of Its IPO 5/7/2015
TetraLogic Pharmaceuticals (TLOG) Announces Termination Of Public Offering 5/6/2015
CoLucid Pharma Announces Pricing Of IPO 5/6/2015
Adaptimmune Announces Pricing Of IPO 5/6/2015
OpGen Announces Pricing Of IPO 5/5/2015
Blueprint Medicines (BPMC) Announces Closing of Initial Public Offering 5/5/2015
Viking Therapeutics Announces Closing Of Initial Public Offering 5/5/2015
As Market Froths, Blueprint Medicines (BPMC) Debuts $147 Million IPO for Massachusetts' Biggest Recent IPO 5/1/2015
Arcadia Biosciences Commences Initial Public Offering 5/1/2015
Ligand Pharmaceuticals Inc. (LGND) Partner Viking Therapeutics Announces Pricing Of IPO 4/29/2015
Aduro Biotech (ADRO) Announces Close Of IPO, Including Full Exercise Of Underwriters’ Option To Purchase Additional Shares, And Concurrent Private Placement 4/20/2015
XBiotech USA (XBIT) Closes IPO 4/17/2015
KemPharm Announces Pricing Of IPO 4/16/2015
XBiotech USA, Inc. Announces Pricing Of Initial Public Offering 4/16/2015
Cidara Therapeutics Announces Pricing Of IPO 4/15/2015
Carbylan Therapeutics Announces Closing Of IPO And Full Exercise Of Underwriters' Option To Purchase Additional Shares 4/15/2015
Forward Pharma (FWP) Pre-IPO Investors Voluntarily Agree To Extend Lock-Up 4/10/2015
BioPharmX Files Registration Statement For Proposed Public Offering 4/10/2015
Carbylan Therapeutics Announces Pricing Of Initial Public Offering 4/9/2015
SanBio, Inc. Announces Pricing Of Initial Public Offering On Tokyo Stock Exchange 4/8/2015
Bone Repair Biotech PolyPid Ltd. Yanks $20M IPO As Selloff Continues 3/27/2015
SteadyMed (STDY) Announces Closing of Initial Public Offering 3/26/2015
With Alexion (ALXN) Deal in Hand, Blueprint Medicines Preps for $100 Million IPO 3/24/2015
SteadyMed (STDY) Announces Pricing Of Initial Public Offering 3/20/2015
Juno Therapeutics (JUNO) Post IPO: Ups and Downs But Mostly Ups 3/18/2015
Summit Therapeutics Announces Closing Of Its U.S. Initial Public Offering 3/11/2015
Backed By a Genentech (RHHBY) Alum, NGM Looks Like it Could be the Next Biotech IPO 3/5/2015
Summit Therapeutics Announces Pricing Of U.S. Initial Public Offering And Nasdaq Global Market Listing 3/5/2015
Malin, Formed by Ex-Elan (ELN) Execs, Eye Up to $365 Million in Biotech IPO 3/4/2015
Medtronic (MDT), Leading Neurostimulation Company, Invests In Flex Pharma (FLKS) IPO 3/3/2015
Check-Cap Announces Closing Of Initial Public Offering And Simultaneous Private Placement 2/25/2015
Inotek Pharmaceuticals Corporation Announces Closing Of Initial Public Offering And Convertible Senior Notes Offering 2/24/2015
EyeGate Pharma Announces Closing Of Initial Public Offering Of Approximately $4,100,000 Of Common Stock 2/20/2015
Bellerophon Therapeutics (BLPH) Announces Closing Of Its Initial Public Offering 2/20/2015
Check-Cap Announces Pricing Of Initial Public Offering And Expects To Raise $24.0 Million In IPO And Simultaneous Private Placement 2/19/2015
Inotek Pharmaceuticals Corporation Announces Pricing Of Initial Public Offering Of 6,667,000 Shares Of Common Stock And 5.0% Convertible Senior Notes Due 2020 2/18/2015
VolitionRX Announces Exercise Of Over-Allotment Option In Previously Announced Public Offering 2/17/2015
EyeGate Pharma Prices $4,100,000 Initial Public Offering 2/13/2015
Nexvet Biopharma Announces Closing Of Initial Public Offering 2/11/2015
Bay Area's SteadyMed (STDY) Files for $55 Million IPO 2/9/2015
GlaxoSmithKline (GSK) Brings Three Banks on Board to Advise on Potential IPO 2/5/2015
BBI Life Sciences Stages $37 Million IPO in Hong Kong 2/5/2015
Flex Pharma (FLKS) Announces Closing Of Initial Public Offering 2/4/2015
Unilife Corporation (UNIS) Announces Public Offering Of Common Stock 1/30/2015
Spark Therapeutics (ONCE) Announces Pricing of Its Initial Public Offering 1/30/2015
Boston's Flex Pharma (FLKS) Upsizes IPO to $86 Million 1/29/2015
Zosano Pharma, Inc. Announces Pricing Of Initial Public Offering 1/27/2015
Biotech IPOs Up 22% Since "Bubble" Year of 2000, Shows New Data 1/19/2015
Evolving GlaxoSmithKline (GSK) Mulls Over More Unit IPOs 1/16/2015
Cantargia Performs IPO Ahead Of Planned Listing On Nasdaq First North In Stockholm 1/16/2015
Cellectis (ALCLS) Plans To Conduct Registered Initial Public Offering In The U.S. 1/9/2015
Bellicum Pharmaceuticals, Inc. Announces Closing Of Initial Public Offering And Exercise Of The Underwriters’ Option 12/24/2014
Juno Therapeutics (JUNO) Announces Closing Of Initial Public Offering, Including Full Exercise Of Underwriters’ Option To Purchase Additional Shares 12/24/2014
Juno Therapeutics Announces Pricing Of Initial Public Offering 12/19/2014
Amazon.com (AMZN)-Backed Juno Therapeutics Aims Even Higher; Eyes $212 Million IPO 12/18/2014
CB Pharma Acquisition Corp. Announces Closing Of Initial Public Offering 12/18/2014
Selvita Has Raised PLN 27.3 MM On Its Way To The Main Market Of The Warsaw Stock Exchange 12/16/2014
CB Pharma Acquisition Corp. Announces Pricing Of Initial Public Offering 12/15/2014
Coronado Biosciences (CNDO) Announces Pricing Of Initial Public Offering Of CB Pharma Acquisition Corp. 12/15/2014
Houston-Based Bellicum Pharmaceuticals, Inc. Sets Terms For $100 Million IPO 12/12/2014
Lucky Juno Therapeutics (JUNO) Sets Terms For Biggest IPO Of 2014: $191 Million 12/11/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data 12/3/2014
FibroGen, Inc. (FGEN) Announces Pricing Of Its IPO 11/14/2014
Coherus Biosciences Prices Initial Public Offering Of $85 Million Of Common Stock 11/6/2014
Xenon Pharmaceuticals Inc. Announces Pricing Of Initial Public Offering 11/5/2014
SF's Billion Dollar Biotech FibroGen, Inc. Sets Terms For $124 Million IPO 10/31/2014
Boston’s Rhythm Withdraws $86 Million IPO Citing Acquisition Agreement With Actavis (ACT) 10/30/2014
Bay Area's Coherus Biosciences Sets Terms For $85 Million IPO 10/27/2014
Job Cuts Loom Over GlaxoSmithKline (GSK) As It Aims To Cut Costs; Eyes IPO Of HIV Unit 10/23/2014
Current Climate The Best For Biotech IPOs In Decades, Says VC 10/20/2014
VBL Therapeutics (VBLX) Announces Closing Of Initial Public Offering 10/7/2014
Bay Area Biotech Dermira Increases Deal Size 46% To $117 Million 10/3/2014
FibroGen, Inc. Files Registration Statement For Proposed Initial Public Offering 10/3/2014
Titan Pharmaceuticals (TTP) Announces Pricing Of Public Offering 10/3/2014
Forward Pharma (FWP) Announces Proposed IPO Of ADSs 10/2/2014
SSF's Calithera Biosciences, Inc. (CALA) Prices IPO At $10 A Share, Below The Range 10/2/2014
VBL Therapeutics (VBLX) Announces Pricing Of Initial Public Offering 10/1/2014
Vitae Pharmaceuticals, Inc. (VTAE) Announces Closing Of Initial Public Offering 9/29/2014
Bay Area Biosimilar Firm Coherus Biosciences Eyes $86.25 Million IPO 9/26/2014
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Closing Of Initial Public Offering 9/24/2014
Tokai Pharmaceuticals (TKAI) Announces Closing Of Initial Public Offering 9/24/2014
Swiss Biotech Firm Molecular Partners AG Plans $134 Million IPO 9/23/2014
Bay Area's Dermira Supersizes IPO Up 30% To $98M 9/22/2014
Affimed Therapeutics AG (AFMD) Announces Closing Of Initial Public Offering 9/18/2014



//-->